A network of global premier minds

Our network

Our in-house skillset is complemented with a trusted global network of top-tier experts, carefully selected to match the geography, asset, and phase of development. Their input fuels innovative, locally tailored insightsintegrated harmoniously with our internal strategic analysis ​

Our agile structure & iterative approach ensure fast mobilization, continuous engagement, and pragmatic, solution-oriented recommendations that drive real-world access success — delivering high-quality insights at speed, without compromising scientific integrity or local relevance

Partners Scientific committee

36
Countries covered 


220
Payer & HTA experts

Illustration - Map
Map
Daniel Lew
MD, MBA
INTERNATIONAL PARTNER | Argentina
David Cunningham
MD, MSc
INTERNATIONAL PARTNER | UK
Edmund Pezalla
MD, MPH
INTERNATIONAL PARTNER | USA
Eric Aubert
MD, MBA
EXECUTIVE SEARCH
Folkert de Groot
ToendersdeGroot B.V.
INTERNATIONAL PARTNER | Netherlands
George Dranitsaris
B.Sc. Pharm, MSc, PhD
INTERNATIONAL PARTNER | Canada
Lars-Åke Levin
PhD
INTERNATIONAL PARTNER | Sweden
Marc Czarka
MD
INTERNATIONAL PARTNER | BELGIUM
Maria Lopes
MD
INTERNATIONAL PARTNER | USA
Mathias Flume
PhD, MBA, Pharm D
INTERNATIONAL PARTNER | GERMANY
Oriol-Sola Morales
MD, PhD
INTERNATIONAL PARTNER | Spain
Rodrigo Antonini Ribeiro
MD, PhD, MBA
INTERNATIONAL PARTNER | Brazil
Ulf Maywald
M.Sc, Pharm.D
INTERNATIONAL PARTNER | GERMANY
Valentina Drago
PharmD, PhD
INTERNATIONAL PARTNER | Italy
Wenhui Mao
PhD
INTERNATIONAL PARTNER | China

 

Scientific committee

Our Scientific Committee advises Medi-Qualité Omega to stay at the cutting edge of market access science and drive impactful results for our clients, we draw on the continued expertise of our Scientific committee and trusted international partners​. Their insights are instrumental in shaping our strategic direction, spotting emerging trends, and constructively challenging our assumptions​. Their expertise helps our consulting team stay ahead of the curve—proactively anticipating regulatory changes, evolving HTA expectations, and shifting definitions of value. This allows us to provide timely, dependable, and market-sensitive assessments that evolve in real time with our clients' needs​

 

NB: Each scientific committee member is entirely independent and does not speak on behalf of their own institution.

Caroline Robert
MD, PhD
SCIENTIFIC COMMITTEE
Filippo Drago
PhD
SCIENTIFIC COMMITTEE
Gilles Bouvenot
MD, PhD
Scientific Committee
Gordon Liu
PhD
Scientific Committee
Isao Kamae
M.D., D.Ph.
Scientific Committee
Loïc Guillevin
MD, PhD
Scientific Committee
Mamoru Narukawa
PhD
Scientific Committee
Mercedes Martínez Vallejo
M.Sc
Scientific Committee
Stéphane Jaffard
PhD
Scientific Committee
Thomas Lee
MSc, MD, BA
SCIENTIFIC COMMITTEE
Wen Chen
MD, PhD, Prof.
Scientific Committee
Willard Dere
MD, PhD, Prof.
SCIENTIFIC COMMITTEE
Yvonne-Beatrice Boehler
MD, MBA, Prof.
SCIENTIFIC COMMITTEE

 

Our firm collects your personal data in order to respond your request. Please fill in all the required fields. If you wish to access, delete or modify your data, please send an email to contact@mediqualite.com including "MY DATA" in the subject header.


MQO

27 rue Blomet
75015 Paris
France
+33 (0)9 66 97 82 58